Mean platelet volume in patients with nonvalvular atrial fibrillation

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 5, 2013, Pages 537-539

  Tekin, Gulacan ^a   Tekin, Yusuf Kenan ^b   Sivri, Nasr ^c   Yetkin, Ertan ^d  

^a BOZOK UNIVERSITY   (Turkey)

^b Yozgat State Hospital Emergency Service   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d Ortadogu Hospital   (Turkey)

Author keywords

Atrial fibrillation; mean platelet volume; platelet activation; white blood cell

Indexed keywords

AGED; ARTICLE; BLOOD CELL COUNT; CARDIAC PATIENT; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ERYTHROCYTE COUNT; FEMALE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; SINUS RHYTHM; SMOKING; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD CELL COUNT; BLOOD PLATELETS; CELL SIZE; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PLATELET ACTIVATION; RETROSPECTIVE STUDIES;

EID: 84879945079     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835facb3     Document Type: Article

References (23)

1. Lake FR, Cullen KJ, de Klerk NH, Mc Call MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989; 19:321-326.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
3. Feng D, D'Agostino BR, Silberschatz H, Lipinska I, Massaro J, Levy D, et al. Hemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol 2001; 87:168-171.
4. Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn Circ J 1981; 22:143-149.
5. Yamaguchi K, Furui H, Taniguchi N, Sotobata I. Plasma b-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 1986; 27:481-487.
6. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21:47-51.
7. Lip GYH, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, et al. Fibrin D-dimerand b-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation 1996; 94:425-431.
8. Atalar E, Haznedaroglu IC, Acil T, Ozer N, Kilic H, Ovunc K, et al. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets 2003; 14:407-411.
9. Li-Saw-Hee FL, Blann AD, Lip GYH. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Eur Heart J 2001; 22:1741-1747.
10. Atalar E, Ozmen F, Haznedaroglu I, Ozer N, Aksoyek S, Ovunc K, et al. Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheumatic atraial fibrillation. Int J Hematol 2002; 76:192-195.
11. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32:443-460.
12. Van der Loo B, Martin JF. A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999; 19:672-679.
13. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117:399-404.
14. Van der Loo B, Martin JF. Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 1997; 10:109-123.
15. Senaran H, Ileri M, Altinbas A, Kosar A, Yetkin E, Ozturk M, et al. Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 2001; 24:405-408.
16. Yetkin E. Mean platelet volume not so far from being a routine diagnostic and prognostic measurement. Thromb Haemost 2008; 100:3-4.
17. Lip GYH. The prothrombotic state in atrial fibrillation: the atrium, the endothelium and tissue factor? Thromb Res 2003; 111:133-135.
18. Blann AD. Angiogenes is and platelets: the clot thickens further. Cardiovasc Res 2004; 63:192-193.
19. Choudhury A, Chung I, Blann AD, Lip GY. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of 'healthy control subjects' and 'disease control subjects' in sinus rhythm. JAm Coll Cardiol 2007; 49:1957-1964.
20. Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, et al. Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased plateletactivation? Blood Coagul Fibrinolysis 2008; 19:411-414.
21. Atak R, Turhan H, Senen K, Yalta K, Ayaz S, Alyan O, et al. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis. J Heart Valve Dis 2004; 13:159-164.
22. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006-3010.
23. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrateof atrial biopsies in patientswith loneatrialfibrillation. Circulation 1997; 96:1180-1184.